Characteristic | n | (%) |
---|---|---|
Gender | ||
Male | 54 | 75.0 |
Female | 18 | 25.0 |
Age (year) | ||
Median | 60 | |
Range | 21-80 | |
ECOG PS | ||
0 | 23 | 31.9 |
1 | 49 | 68.1 |
Hepatitis | ||
No | 2 | 2.8 |
Yes | 70 | 97.2 |
HBV | 52 | 72.2 |
HCV | 6 | 8.3 |
Others | 12 | 16.7 |
Liver cirrhosis | ||
No | 16 | 22.2 |
Yes | 56 | 77.8 |
PVTT | ||
No | 30 | 41.7 |
Yes | 42 | 58.3 |
AFP (IU/mL) | ||
<400 | 48 | 66.7 |
≥400 | 24 | 33.3 |
Child-Pugh class | ||
A | 54 | 75.0 |
B | 18 | 25.0 |
AJCC stage | ||
II | 12 | 16.7 |
III | 53 | 73.6 |
IVA | 7 | 9.7 |
Previous treatment | ||
No | 7 | 9.7 |
Yes | 65 | 90.3 |
TACE | 63 | 87.5 |
RFA | 7 | 9.7 |
PEI | 7 | 9.7 |
Surgery | 9 | 12.5 |
Treatment after RT | ||
No | 31 | 43.1 |
Yes | 41 | 56.9 |
TACE | 40 | 55.6 |
RFA | 2 | 2.8 |
PEI | 2 | 2.8 |
Systemic CTx | 3 | 4.2 |
Radiation dose | ||
40 Gy/10 fxs | 6 | 8.3 |
45 Gy/10 fxs | 10 | 13.9 |
50 Gy/10 fxs | 56 | 77.8 |